NCT00514904View on ClinicalTrials.gov

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

1,504

Participants

Timeline

Start Date

September 18, 2007

Primary Completion Date

September 3, 2008

Study Completion Date

January 6, 2009

Conditions
Infections, MeningococcalMeningococcal Vaccines
Interventions
BIOLOGICAL

Nimenrix

Single dose, intramuscular injection

BIOLOGICAL

Mencevax

Single dose, subcutaneous injection

Trial Locations (7)

1008

GSK Investigational Site, Sampaloc, Manila

110002

GSK Investigational Site, New Delhi

403202

GSK Investigational Site, Goa

452001

GSK Investigational Site, Indore

632004

GSK Investigational Site, Vellore

1107-2020

GSK Investigational Site, Beirut

Unknown

GSK Investigational Site, Riyadh

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY